MyAverix Finance
TWO · Healthcare
Welgene Biotech Co.Ltd. (6661)
Diagnostics & Research
Welgene Biotech Co.Ltd. (6661) is listed on TWO in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-29, reported market cap is $450.94M, P/E ratio is 322.50, net margin is 0.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6661
Welgene Biotech Co.Ltd. (6661) — FAQ
What is Welgene Biotech Co.Ltd.'s market cap?
Welgene Biotech Co.Ltd. (6661) has a reported market cap of $450.94M (data as of 2026-03-29).
What is 6661's P/E ratio?
The price-to-earnings (P/E) ratio for Welgene Biotech Co.Ltd. (6661) is 322.50 (data as of 2026-03-29).
Does Welgene Biotech Co.Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Welgene Biotech Co.Ltd. (6661). Check the MyAverix Finance app for the latest dividend data.
What sector is Welgene Biotech Co.Ltd. in?
Welgene Biotech Co.Ltd. (6661) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 6661 listed on?
6661 is listed on TWO.
What is Welgene Biotech Co.Ltd.'s net margin?
Welgene Biotech Co.Ltd. (6661) reports a net margin of 0.4% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.